Nav: Home

Ari Waisman receives most prestigious European prize for MS research

December 15, 2016

The Sobek Foundation honors Professor Ari Waisman for his groundbreaking achievements in research into multiple sclerosis (MS). His research results are regarded as crucial for the understanding of the mechanisms underlying the disease and as a major contribution to the successful development of modern anti-inflammatory and immunomodulatory therapies. Moreover, Waisman's discoveries on the damage to tissues associated with MS may well form the basis of new preventative treatments to limit tissue degeneration.

Professor Ari Waisman is Director of the Institute for Molecular Medicine at the University Medical Center of Johannes Gutenberg University Mainz (JGU). His research has enabled "a deeper insight into the role and regulation of inflammatory cells in the brain," the Sobek Foundation argued. Waisman prepared the ground for the analysis of certain harmful cell functions. In doing so, he has made a major contribution to our understanding of the mechanisms of auto-immune diseases, which are the cause of chronic inflammatory tissue damage. Thus he has "contributed to the successful development of modern anti-inflammatory and immunomodulatory therapies."

The Sobek Foundation also regards Waisman as being the driving force behind the development of so-called neuro-protective forms of therapy. These are treatments designed to slow down the progression of a neurodegenerative disease and alleviate its symptoms. In concrete terms, these forms of therapy are aimed at counteracting tissue degeneration.

Ari Waisman, who was born in Rio de Janeiro, studied biology in Israel and completed his PhD on immuno-biology in Rehovot, Israel. He conducted research under renowned immunologists in Israel and later at the University of Cologne. In 2005, he was appointed Professor of Immunology at the Mainz University Medical Center, where he was section head in the Department of Internal Medicine I for five years. In 2010, he was promoted to the post of Director in the Institute for Molecular Medicine of the Mainz University Medical Center.

At the award ceremony for the current Sobek Research Prize, laudator Ulrich Steinbach, Director General in the Ministry of Science, Culture and Art in Baden-Württemberg, highlighted the wide international recognition for Professor Ari Waisman's research achievements. Dr. Ari Waisman has published the results of his research in over 170 scientific papers since 1990, including many successful collaborations with other scientists in the field of MS research.

The Research Prize of the Roman, Marga and Mareille Sobek Foundation, this year awarded jointly with AMSEL e.V. and the German Multiple Sclerosis Society (DMSG), has now been awarded 17 times for research into multiple sclerosis research.
-end-


Johannes Gutenberg Universitaet Mainz

Related Multiple Sclerosis Articles:

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.
Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.
New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.
Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).
The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.
Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.
7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients
AAN issues guideline on vaccines and multiple sclerosis
Can a person with multiple sclerosis (MS) get regular vaccines?
How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.
Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.
More Multiple Sclerosis News and Multiple Sclerosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

How to Win Friends and Influence Baboons
Baboon troops. We all know they're hierarchical. There's the big brutish alpha male who rules with a hairy iron fist, and then there's everybody else. Which is what Meg Crofoot thought too, before she used GPS collars to track the movements of a troop of baboons for a whole month. What she and her team learned from this data gave them a whole new understanding of baboon troop dynamics, and, moment to moment, who really has the power.  This episode was reported and produced by Annie McEwen. Support Radiolab by becoming a member today at Radiolab.org/donate.